Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion type Assertion NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_head.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion description "[Compared to controls, a significantly higher percentage of CD16 and CD35+ monocytes from XLA (P = 0.002 and P = 0.007, respectively) were observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_provenance.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion evidence source_evidence_literature NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_provenance.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion SIO_000772 17900300 NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_provenance.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion wasDerivedFrom befree-20150227 NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_provenance.
- NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_assertion wasGeneratedBy ECO_0000203 NP397218.RA3_Kw4rxZzStFNGKikF3V34SX_ULnZQXMnF2tVLlj3kA130_provenance.